Mark Noviski

Q: What is Mark Noviski email address?

Email Mark Noviski at mnoviski@nurixtx.com. This email is the most updated Mark Noviski email found in 2026.

Q: How to contact Mark Noviski?

To contact Mark Noviski send an email to mnoviski@nurixtx.com.

Associate Director, Cell Biology and Project Lead at Nurix Therapeutics | San Francisco, California, United States

About Mark Noviski

Mark Noviski serves as a Principal Scientist in Cell Biology and Project Lead at Nurix Therapeutics, where he leverages his extensive background in both academia and industry to drive innovative research in targeted protein degradation. With a robust portfolio that spans autoimmunity, cell biology, biochemistry, microbiology, and genetic engineering, Mark has established himself as a key contributor to the advancement of therapeutic strategies aimed at modulating immune responses and addressing complex diseases.

In his current role, Mark leads a collaborative program focused on the development of novel clinical assets, managing a team of two direct reports, including a Senior Scientist II and a Research Associate III. His leadership is pivotal in orchestrating cross-functional efforts that integrate cutting-edge techniques such as Polymerase Chain Reaction (PCR), Western Blotting, and ELISA to elucidate cell signaling pathways and their implications in disease mechanisms. Mark's expertise in mouse models of autoimmune disease allows him to design and implement experiments that yield critical insights into immune receptor signaling, thereby informing the development of targeted therapies.

Mark's proficiency in cell culture and biochemistry, combined with his adeptness in utilizing tools like Adobe Illustrator for data visualization and Microsoft PowerPoint for impactful presentations, enables him to communicate complex scientific concepts effectively to both technical and non-technical audiences. His commitment to personal development and continuous learning ensures that he remains at the forefront of scientific advancements, positioning Nurix Therapeutics as a leader in the field of targeted protein degradation and therapeutic innovation.

Mark Noviski Work